SkySea Pharmaceutical

Italy
Corpo di Cava, Campania, Italy

Company profile

SkySea Pharmaceutical company profile

SkySea Pharmaceutical is a Commercialization of the world's first autism spectrum medicine and related businesses.We conduct research and development of therapeutic agents for autism spectrum disorders based on oxytocin based on the research results of Hokkaido University and Kanazawa University .

Business identity

Phone number
011-299-6595
Operating status
Active
Company type
For Profit
Revenue range
$50,000+
Founded
2015-03-31

Headquarters

Country code
IT
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Last funding
Seed / 2016-08-05
Last equity funding
Seed
Investors
1
Lead investors
1
Founders
1

Founders and investors

Founders

Yuji Kogami

Lead investors

SARR

Investors

SARR